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AB ST RACT  
Vaccination is without doubt the most useful single measure available to p revent animal 
infectious diseases. The advantages of vaccination are numerous. It is the only available method 
to prevent, or sometimes cure, viral animal infections in the absence of broad spectrum 
antivirals and avoids the alternative of mass slaughtering of livestock. 
Antibiotic or anthelmintic resistance, and the problem of pharmaceutical residues, promote the 
use of vaccines rather than chemotherapy. Vaccines are environmentally friendly and increase 
animal welfare by preventing suffering from disease resulting from treatment for a cure which 
may result in antibiotic resistance and pharmaceutical residues in food. For the management of 
livestock health vaccines are the best tool to achieve sustainability.  
Veterinary vaccines cannot only be used to protect animal health but also human health from 
zoonotic infections through animal vaccination as exemplified by wildlife vaccination against 
rabies. In animal health the focus is now on animal infections rather than on animal diseases. 
Vaccines should be designed to prevent infection rather than to prevent clinical signs of disease 
and should, wherever possible, produce sterile immunity. 
Available technologies allow us to design "marker" vaccines together with their companion 
diagnostic tests which permit the distinction between vaccinated and infected animals even if 
the latter were previously vaccinated. Examples will be given of foot-and-mouth disease, 
classical swine fever, and herpesvirus infections of livestock such as pseudorabies or infectious 
bovine rhinotracheitis where carrier state or latency remain an issue after vaccination.  
. 
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Smallpox was the first viral infection to be eradicated worldwide. This remarkable success was 
due to several factors including the availability of an efficacious vaccine, namely vaccinia, and 
the absence of a wildlife reservoir. According to the World Health Organisation (WHO) 
eradication of human poliomyelitis and measles may be possible in the same manner.  
The only animal virus disease which currently shares the same characteristics is rinderpest; 
there are several efficacious vaccines already available and the infection seems to be a dead -end 
if transmitted to susceptible wild species. Other animal viral infections do not share the same 
characteristics, either due to the lack of an efficacious vaccine (African swine fever) or to the 
existence of wildlife reservoirs such as the wild boar (Sus scrofa) for classical swine fever, the 
African buffalo (Syncerus caffer) for foot-and-mouth disease, bats for lyssavirus infections, etc. 
These diseases are more prone to a regional elimination than to complete eradication 
worldwide. Two methods are used to eliminate an animal viral infection, either vaccination or 
the strict application of hygienic measures including “stamping out” and incineration, or an 
integration of both methods. 
Public opinion is increasingly concerned about stamping out, even when necessary, such as 
when dealing with emerging zoonosis, such as Nipah virus infection of pigs in Malaysia. On the 
other hand, generalised vaccination (foot-and-mouth disease, classical swine fever, etc.) may be 
discontinued despite its efficacy, for macro-economical reasons. The solution may come from the 
use of marker vaccines associated with companion diagnostic tests which allow a distinction 
between infected animals and those which have been vaccinated, using serological examination, 
such as for pseudorabies in pigs and infectious bovine rhinotracheitis. Some diseases, such as 
rabies, may raise questions despite the success of fox vaccination campaigns and the progressive 
elimination of terrestrial wildlife rabies in Europe. The existence of a permanently potential 
wildlife reservoir in bats is a threat, taking into consideration the variability of RNA viruses 
(quasi-species). 
This paper will focus not only on viral infections of animals for which no broad range 
pharmaceuticals exist, vaccines or slaughtering being the only alternatives, but also on bacterial 
infections because of the emergence of antibiotic resistance and the increase in food-poisoning 
in humans. 
When discussing the control of infections in animals it is necessary to consider different 
situations, including true eradication (i.e. smallpox), regional elimination or, more often, merely 
control. 
Eradication means the complete elimination of the infection/disease worldwide; as mentioned, 
only one disease has been eradicated so far, smallpox. A similar simian infection still prevails. 
The only animal disease which may be eradicated in the same way, because it posse sses the 
same characteristics necessary for eradication, is rinderpest. According to Fenner, the 
characteristics of the disease which permitted the eradication of smallpox were:  
1.that it was an important and "serious" disease; 
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2.the absence of sub-clinical infection or silent excretion; 
3.the animals were not contagious during the incubation or prodromic periods; 
4.the absence of asymptomatic carriers or recurrent access of excretion or disease; 
5.one virus serotype; 
6.the availability of an efficacious and stable vaccine; 
7.seasonal incidence; 
8.no alternative reservoir. 
The other 15 important animal diseases in OIE List A (OIE, 1982) do not exhibit all these 
characteristics. 
OIE LIST A DISEASES 
-Foot-and-mouth disease 
-Vesicular stomatitis 
-Swine vesicular disease 
-Rinderpest 
-Peste des petits ruminants 
-Contagious bovine pleuropneumonia 
-Lumpy skin disease 
-Rift valley fever 
-Bluetongue 
-Sheep pox and goat pox 
-African horse sickness ; 
-African swine fever 
-Classical swine fever (hog cholera) 
-Highly pathogenic avian influenza 
-Newcastle disease 
The OIE List A diseases are defined as highly contagious animal diseases which  are particularly 
damaging to the national or regional economy. Some of them are zoonotic (Rift Valley fever, 
Newcastle disease), but this characteristic is not necessarily required for them to belong to List 
A. 
As an example, foot-and-mouth disease has a reservoir in wildlife, the african buffalo (Syncerus 
caffer), and therefore eradication is impeded in the short term. The elimination of an animal 
viral disease must take into account the biologica an epidemiological characteristics of the 
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infection, the available control methods an e emergence of new vaccination technologies such as 
marker vaccines. 
A Plea for Veterinary Vaccines 
Why should we develop veterinary vaccines? The reasons are manifold:  
1.to protect animal health; 
2.to improve animal welfare; 
3.to protect public health; 
4.to protect consumers from the products from food-producing animals; 
5.to protect the environment and biodiversity; 
6.to avoid the emergence of pathogens resistant to available drugs;  
7.to promote sustainable agriculture and animal production. 
Unfortunately, even though the reasons for developing veterinary vaccines are many, there are 
still many obstacles to their development: 
1.scientific obstacles (e.g. African swine fever, many anti-parasitic vaccines); 
2.poor investment return for the companies involved in vaccine development and production;  
3.the existence of so-called “minor” species as targets; 
4.the existence of conditions of minor importance in so-called “major” species; 
5.the existence of conditions of minor importance in so-called “minor” species (the worse case 
scenario); 
6.the existence of interdiction due to animal health regulations;  
7.regulatory requirements for vaccine registration. 
This contribution will illustrate the role of veterinary vaccines in animal health and welfare and 
discuss their potential impact on public health. 
Eradication of Rinderpest 
Morbilliviruses have infected animals and man since the time of early civilisations, 5,000 to 
6,000 years ago. These civilisations presented, for the first time, large populations of susceptible 
animals and people, a fact which guaranteed the presence of young naive individuals in sufficient 
numbers; this is a prerequisite for the persistence of such fragile agents as morbilliviruses which 
provoke a very short infection and produce a life-long sterile immunity. 
The epizootic of rinderpest in 376-386AD was the first to be formally recognised in historical 
documents. This epizootic spread from Eastern Europe, devastated Flanders and terminated in 
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Italy. The expansion of rinderpest was always encouraged by wars, civil troubles and natural 
calamity. These disorders provoked migration within a country or across boundaries. In Africa 
transhumance (the seasonal movement of livestock) contributed to the dissemination of the 
disease. In Europe rinderpest was the major plague of cattle up to the end of the 19,h century 
when it was eliminated. Unfortunately in 1920 there was an accidental outbreak of rinderpest in 
Belgium. An infected zebu herd coming from India to Brazil, through the harbour of Antwerp, 
reintroduced the disease. These animals stayed approximately 15 days in quarantine where they 
contaminated American beef cattle which were afterwards sent to the markets of Brussels and 
Ghent. 
In Ghent these cattle contaminated others from Germany which were afterwards sent all over 
the country thus propagating the disease and initiating many secondary outbreaks. Th e disease 
was only recognised after three weeks despite the death of seven zebus in Antwerp. Prophylactic 
measures (slaughtering, sequestration, disinfection) were applied and the disease was 
eliminated after approximately five months (August 1920 to January 1921). The reintroduction 
of rinderpest into continental Europe highlighted the necessity for international collaboration to 
combat the major contagious diseases of domestic and wild animals. Worried because of the 
extension of rinderpest to Belgium, France organised an international meeting to co-ordinate 
measures to contain contagious diseases of domestic animals worldwide. This meeting resulted 
in the creation of the Office International des Epizooties (OIE). Following the pioneer work of 
Walter Plowright in East Africa, systematic vaccination of cattle using an attenuated strain of 
rinderpest virus will most probably lead to the eradication of rinderpest; it will be the first 
animal disease to be eradicated and only the second one following the eradication of smallpox. 
New recombinant vaccines are now available. The main problem which remains is the 
circulation of hypovirulent strains in East Africa, mainly in Kenya, and the coexistence of a 
similar disease in small ruminants (peste des petits ruminants); once the problem of rinderpest 
is solved the same strategy may be applied to the eradication of peste des petits ruminants.  
The mode of transmission of rinderpest is direct and cattle are the only reservoir of the 
infection. Wild artiodactyls are highly susceptible to the infection and develop a fatal disease 
which may contribute to virus dissemination but this constitutes a deadend infection. The 
struggle to eradicate rinderpest is, therefore, limited to domestic cattle and the best tool for 
eradication is vaccination. 
Marker Vaccines and Companion Diagnostic Tests 
In animal health the alternatives are to vaccinate animals to prevent disease or attempt to 
eliminate infection through strict application of sanitary measures such as the slaughtering of 
infected and in-contact animals. For diseases for which vaccines do not exist (e.g. African swine 
fever), and particularly for zoonoses (e.g. Nipah virus infection of pigs), the systematic 
slaughtering of animals is, at present, the only available solution. This will not be acceptable in 
the near future. Diagnosis of infection is of paramount importance. Diagnosis can be direct 
through the detection of the infectious agent using immunological or molecular technologies; a 
good example is the detection of persistently infected cattle with bovine viral diarrhoea (BVD) 
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virus. Polymerase chain reaction (PCR) is generally considered as being highly sensitive. 
However, this involves the use of specialised laboratories and obtaining a diagnosis is often too 
slow. 
Other diagnostic methods are indirect since they are based upon the detection of specific 
antibodies against the suspected infectious agent. These methods do not give immediate results 
since they depend upon the synthesis of antibodies by the animal after infection or vaccination. 
Indirect methods also do not generally distinguish between the humoral immune response 
resulting either from an infection or a vaccination. 
This problem can be overcome by the use of marker vaccines and companion diagnostic tests. 
There are two types of systems used; these are either based on the detection of a serological 
response against a protein, the gene for which has been deleted in the vaccine strain (either only 
one deletion or a sub-unit vaccine), or on the detection of the serological response towards non-
structural proteins (purified vaccines). In the case of the deletion of a gene coding for a non -
essential protein the marker characteristic is always linked to the deleted protein; in the case of 
sub-unit vaccines (e.g. protein E2 of classical swine fever virus) the choice of the marker may be 
linked to several other proteins. To standardise tests a choice must be made (e.g. protein gE of 
Pseudorabies virus). In the first type of marker vaccines, the marker must always be negat ive 
since a positive marker, for instance through the insertion of a gene coding for a foreign protein, 
is not suitable; it will only demonstrate that an animal has been vaccinated but not whether the 
animal was also infected. Due to their capacity to detect infected animals, either vaccinated or 
not, marker vaccines must always be associated with a companion diagnostic test which can be 
used during a prophylactic campaign to eliminate infection. If marker vaccines are used in such a 
situation they must have an epidemiological impact. 
Vaccines which have been developed to prevent animal disease were mainly designed to prevent 
clinical signs without realising the epidemiological impact of vaccination on the excretion of wild 
virus following infection and on its dissemination and circulation. There can be a problem if 
virus multiplication is inhibited to the point that the infection does not induce the synthesis of 
specific antibodies, which may be detected in diagnostic tests.  
The attitude of the general public towards mass slaughtering of infected or in-contact animals is 
changing. A better alternative is the “vaccination for life” (i.e. vaccination which allows animals 
to be kept alive rather than slaughtered). Marker vaccines may help to solve this problem i f they 
show the required characteristics. Unfortunately most of the available companion diagnostic 
tests can only be used for herd certification and not for individual certification.  
 
Marker Vaccines with one Deletion : The example of 
Pseudorabies and Infectious bovine Rhinotracheitis 
Pseudorabies in pigs and infectious bovine rhinotracheitis are two infections caused by 
herpesviruses which become latent in an animal even when it has already been vaccinated. The 
first marker vaccine was available for pseudorabies infection in pigs due to the existence of an 
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attenuated strain of pseudorabies virus developed by Bartha in Hungary (1961), which was 
spontaneously deleted in the gE glycoprotein. Analogous vaccines were developed subsequently 
for infectious bovine rhinotracheitis. Vaccination against infectious bovine rhinotracheitis is a 
good example of the application of marker vaccines. Original vaccines against infectious bovine 
rhinotracheitis were designed to prevent clinical signs of the disease after infection of the animal 
with a wild virus. Infectious bovine rhinotracheitis belongs to list B of OIE and the infection may 
have a detrimental impact on the international exchange of animals for countries, particularly 
within the European Union, which wish to eliminate the infection. 
In the European Union several countries have a programme of infectious bovine rhinotracheitis 
elimination. The herpesvirus responsible for infectious bovine rhinotracheitis becomes latent 
after infection, regardless of whether the animal is vaccinated or not. Wild virus can become 
latent in vaccinated animals whether an inactivated or an attenuated vaccine is used and animals 
remain latent carriers, even if vaccinated after the infection with a wild virus. Moreover, 
attenuated vaccine strains become latent after vaccination and this includes gE deleted strains. 
As a consequence, in an area where animals are vaccinated with a conventional (non -deleted) 
vaccine, either attenuated or inactivated, it is impossible to distinguish between vaccinated or 
infected cattle; in an area where vaccination is prohibited, all animals serologically positive to 
infectious bovine rhinotracheitis virus must be considered as potentially infected and latent 
carriers of a wild virus. If an elimination programme is initiated in an area where animals are 
vaccinated with conventional vaccine (undeleted), all the seropositive animals must be 
eliminated from the herd. In fact in those circumstances an animal can either be:  
1.vaccinated; 
2.infected; 
3.vaccinated then infected; 
4.infected then vaccinated. 
A solution may come from the use of a marked/deleted vaccine. The deleted protein in the 
vaccine strain must show the following characteristics: 
1.be a structural protein (inactivated vaccines); 
2.be non-essential in order to be able to produce the vaccine; 
3.not be an essential protective immunogen in order to still have an effective vaccine;  
4.induce a significant and long-lasting humoral immune response in order to be used (when 
deleted) as a marker; 
5.be present in all wild virus strains; 
6.induce a humoral immune response in vaccinated animals when infected.  
If a marker vaccine is used, whenever an animal is seropositive towards the deleted protein, it 
must be seen as infected and eliminated. 
The gD protein of herpesviruses, which is a major protective immunogen, cannot be deleted but 
may be used to develop sub-unit vaccines. 
Published in : Developments in Biologicals (2004), vol.119,  pp.15-29 




The main problem with marker vaccines against infectious bovine rhinotracheitis is their 
epidemiological impact. This must involve their ability to prevent virus circulation when used as 
part of an elimination programme. 
Vaccines capable of inducing a sterile immunity are not currently available. Vaccination 
schedules must be more stringent than those used at present, designed for the protection  
against clinical signs; vaccination must be repeated. Vaccination schedules must be associated 
with strict health measures. For an elimination campaign, epidemiological protection must 
prevent the excretion of wild virus by naïve animals and prevent re-excretion by latently 
infected animals. Attenuated vaccines produced with identical strains, deleted or not, are more 
efficacious than their inactivated counterparts. 
The efficacy of repeated vaccination using an inactivated gE negative vaccine has been stud ied in 
field conditions in the Netherlands. The study showed a significantly reduced incidence of 
seroconversion against wild virus in the vaccinated group compared to the placebo-injected 
control animals. Wild virus circulation without being completely restricted was nevertheless 
significantly reduced. The attenuated gE negative marker vaccine reduced transmission of wild 
virus from infected cattle to naïve animals and in some circumstances even prevented 
transmission. A field experiment confirmed these results and demonstrated that the 
intramuscular administration of an attenuated gE negative vaccine reduced the incidence of 
seroconversion against gE and therefore virus circulation in vaccinated herds as compared to 
control. 
Vaccination against Classical Swine fever and Sub-Unit  
Vaccines 
Classical swine fever caused by a pestivirus is a serious disease belonging to the OIE list A.  
An elimination programme is in place within the European Union; vaccination using 
conventional vaccines is prohibited and a slaughter policy is in place. This policy is challenged by 
the existence of a strong antigenic relationship with other pestiviruses such as the virus 
responsible for bovine viral diarrhoea (BVDZMD) which impedes serological diagnosis, the 
insidious circulation of hypovirulent strains and the presence of a wild reservoir, the wild boar 
(Sus scrofa) in continental Europe. 
Classical, conventional, vaccines with a well-proven efficacy prevented the emergence of 
asymptomatic carriers when they had sufficient potency. Attenuated vaccines were more 
efficacious than their inactivated counterparts. They contributed to the elimination of the 
disease, but they had a disadvantage in creating serologically positive animals; this was not 
acceptable if a slaughtering policy was to be applied. The solution for countries which prohibit 
vaccination but are still facing recunent episodes of classical swine fever may come from the use 
of sub-unit vaccines. 
Sub-unit vaccines have recently been obtained by the expression of the E2 major immunogen of 
classical swine fever virus in a baculovirus system, in vaccinia or pseudorabies virus (El).  
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The baculovirus expression system produced vaccines which allow the distinction between 
infected or vaccinated animals. These vaccines were evaluated and accepted by the European 
Medicinal Evaluation Agency (EMEA); they require the existence of reliable companion 
diagnostic tests which detect the presence of specific antibodies directed against other major 
immunogens of classical swine fever virus, not present in the sub-unit vaccine such as NS2 
protein, a conserved protein. Independent experiments do not confirm the expectations. 
Unfortunately inactivated vaccines are not sufficiently efficacious from the epidemiological 
standpoint as compared to previous classically attenuated vaccines. Moreover, companion 
diagnostic tests currently available are not reliable and therefore limit the possibility of the use 
of these sub-unit vaccines in the field. This is worrying since it seems difficult in Europe to 
eliminate classical swine fever completely without vaccination, particularly since public opinion 
is strongly hostile to slaughtering policies. 
Vaccination against Foot-and-Mouth Disease and Purified 
Vaccines 
Foot-and-mouth disease was first scientifically described during the Renaissance period. Since 
the 17th century there have been many accurate descriptions of this highly transmissible disease 
which became more important after the elimination of rinderpest in Europe. Prophylactic 
measures taken against rinderpest, a directly transmitted contagious infection, were not 
efficacious against foot-and-mouth disease. 
Elimination of foot-and-mouth disease in continental Europe required the mass vaccination of 
cattle and pigs in some countries. Preventive vaccination has been prohibited in the European 
Union since 1991. This prohibition ended a 30-year period of vaccination and consequently 
allowed the progressive appearance of completely naïve cattle herds. This is particularly 
detrimental when the disease is accidentally reintroduced. Since the prohibition of vaccination a 
contingency plan has evolved which is mainly based upon information and the training of the 
partners concerned. The cost of the two schemes (vaccination or information/training) has been 
estimated in France before (in 1990) and after (in 1992) the prohibition of vaccination on the 
basis of an equal efficacy postulate; prohibition of vaccination is a far less costly policy. To 
overcome the risks linked to the complete susceptibility of European l ivestock, concentrated 
antigen vaccine banks have been established and there is now the prospect of using marker 
vaccines in case of an emergency. 
In fact, and when a highly purified vaccine has been used, then whenever an animal is 
seropositive against non-structural proteins coded by the virus (NSP) in an ELISA diagnostic test 
it can be determined that it has been infected by a wild virus. During foot -and-mouth virus 
multiplication the NSP are synthesised at the same level as structural proteins (cleaved 
polyprotein). The NSP are only produced when virus multiplication occurs and are not 
contained within extracellular virions used to produce purified inactivated vaccines. To remove 
contaminating NSP during vaccine production, vaccines must be submitted to a purification 
procedure to ensure that they only contain structural proteins before formulation. Unfortunately 
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the companion diagnostic tests currently available only allow the certification of the absence of 
contamination at herd level but not at an individual level. 
In case a policy of vaccination for life is considered to control foot-and-mouth disease outbreaks, 
it must be possible to distinguish between emergency and preventive vaccines. In the case of an 
emergency vaccination, early onset of protection is important, whereas in case of preventive 
vaccination, the duration of the protection is the main goal.  
Equine Influenza as a Special Case 
A similar approach to foot-and-mouth disease has been applied to equine influenza in a different 
context. When determining real time duration of protection with equine influenza inactivated 
vaccines, it is useful to have a diagnostic tool which allows the exclusion of intercurrent infection 
of the experimental animals with a wild influenza virus. A diagnostic test has been developed by 
the group of Jennifer Mumford at Newmarket in the U.K.; it is based on the serological response 
against a non-structural protein coded by the virus. 
Animal Vaccination for Public Health 
In developed countries, partly as a result of overproduction, public concern for food security has 
been replaced by a major concern about food safety. This concern has increased following the 
BSE outbreak. People are concerned about food poisoning, the presence of drug residues 
following treatment of food-producing animals and the possible transfer of antibiotic resistance 
from bacteria causing disease in livestock to those which affect man. 
Veterinary vaccines may help to solve many of those problems. The best example of a veterinary 
vaccine used for public health purposes is the vaccination of wildlife against rabies; the primary 
goal was not to protect wildlife species from rabies but to prevent human exposure and the 
disease in the human population. 
Being considered as products working by natural mechanisms, vaccines, except for some of their 
excipients, do not need to have an MRL (maximum residue limit) determination associated with 
a withdrawal period. In fact, since vaccine prevention works after a lag period, the use of 
vaccines intrinsically contains a withdrawal period. 
Veterinary vaccines can be used to prevent food poisoning as demonstrated by the “in ovo” 
vaccination of poultry against salmonellosis, in order to decrease carcass contamination. 
Vaccines against sheep cysticercosis have been developed experimentally and may lead to the 
development of similar vaccines to control bovine cysticercosis and thus Taenia saginata 
infestation in humans. 
Bacterial resistance to antibiotics is an emerging problem for both the animal and public health 
sectors. Several antibacterial vaccines used in veterinary medicine disappeared after the second 
world war, and were replaced by antibiotics. The resistance to antibiotics in the animal health 
sector with possible implications (although rarely) for human health as well as the resistance of 
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several parasites to anthelmintics may lead to the reappearance or the appearance of 
antibacterial and antiparasitic vaccines. Even if other pathways such as the selection of food -
producing animals for genetic resistance to disease are followed, the story of Marek’s disease in 
chickens demonstrates that vaccines are often more economical to procure an animal’s 
resistance to pathogens. 
Elimination of Terrestrial Rabies in Europe with a Vectored 
Vaccine 
Elimination of terrestrial rabies is predicted in continental Europe thanks to the use of a 
recombinant vaccinia-rabies vaccine. Through the systematic vaccination of the European 
wildlife reservoir, the fox (Vulpes vulpes) rabies was eliminated from Belgium and other 
European countries. The nucleid acid sequencing of rabies virus strains allowed the 
identification of the source of recontamination of the country in 1994 and a molecular approach 
allowed the identification in a rather simple manner of the origin (vampire bats or terrest rial) of 
human infection in Mexico and the demonstration that the ancestors of lyssaviruses are bat 
lyssaviruses. 
The fact that bats are potential sources of short or long term « spillover » of lyssaviruses 
transmissible by a terrestrial mammal after adaptation poses a problem that cannot be solved 
since one cannot exclude the re-emergence of terrestrial rabies from an aerial source. 
Prevention of Food Poisoning – Impact of Animal 
Vaccination on the Safety of the Food Chain 
Recent news releases have revealed that the U.S. budget will focus on food safety and veterinary 
vaccines mainly to safeguard the U.S. food supply against possible terrorist threats. Among the 
food poisoning threats bacteria such as Salmonella are of paramount importance. Salmonellosis 
is a collective description of a group of diseases caused by bacteria of the genus Salmonella, with 
clinical signs which range from severe enteric fever to mild gastro-enteritis. There are more than 
2,400 serotypes of Salmonella, differentiated by o (somatic) and h (flagella) antigens. All 
serotypes are pathogenic for man, animals or both. One of the characteristics of Salmonella is 
that different serotypes vary in the range of animals that they can infect and cause disease. For 
example, S. typhimurium and S. enteriditis have a very broad host range and infections with 
these serotypes have been associated with virtually all warm-blooded animals. Other serotypes 
have a more limited host range and this has been interchangeably referred to as host -specificity, 
host-restriction or host-adaptation. The highly host-specific serotypes only cause disease in 
phylogenetically closely related host species, for example S. typhi only infects humans, S. 
abortus-ovis only infects sheep and goats, while S. gallinarum only infects poultry. Other 
serotypes are predominantly associated with disease in one species but may also infect a limited 
number of other host species. For example, S. dublin is usually associated with cattle and S. 
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choleraesuis with pigs, but natural infection by these serotypes may occur in other animals, 
including humans. 
Salmonellosis as a disease of humans, cattle, sheep, pigs and poultry is manifested clinically by 
one of three major syndromes: a peracute systemic infection, an acute enteritis or a chronic  
enteritis. Salmonellas may also be carried by animals in the absence of clinical signs and this is 
probably the normal situation in poultry and pigs infected with serotypes other than S. 
pullorum/gallinarum and S. choleraesuis respectively. The “host-adapted” serotype for pigs, S. 
choleraesuis, has virtually disappeared from most of Europe although still prevalent in other 
parts of the world, including the U.S.A. 
It is accepted that Salmonella gastro-enteritis in humans is a zoonotic disease, mainly contracted 
by consuming large numbers of salmonellae in food of animal origin, or foods contaminated with 
animal products or foods in which salmonellae have proliferated. 
The cycle of infection between man and animals is called the “Salmonella cycle”. Infections  in the 
human population are usually associated with the consumption of animal products such as eggs, 
milk and dairy products. Infections in farm animals are usually caused by animal -to-animal 
contact or contaminated feed. It is further complicated by the spread of disease by wild animals 
such as rats, birds and insects and by the recycling of animal products and wastes from one 
animal species to another. An understanding of salmonellosis and the eventual solution to the 
problem may only arise from a study of the disease in many animal species and the manner in 
which the bacteria responsible contaminate the environment, pass from one animal to another, 
cause disease in some and colonise others in the absence of disease.  
The main source of infection for the human population is animal products and the principle 
sources of infection for domesticated livestock are other animals of the same species and 
contaminated feed. Although over 2,400 serotypes of Salmonella have been identified, most 
human and animal disease is caused by just a few of these. The most significant serotypes 
involved change over time for usually quite unknown reasons, although some such as S. 
typhimurium always seem to be present in a variety of species. It is currently impossible to 
predict when and why a serotype or phagetype will decline in prominence, either as a result of 
natural causes or control measures, or when a new serotype is likely to rise in importance, and 
whether it will be a greater or lesser threat to human and animal health. This highlights the 
importance of research to understand the host, bacterial or environmental factors involved  
Control of salmonellosis as an example 
Control of salmonellosis and prevention of food poisoning in the human population depends on: 
(i) reduction of disease and carriage of salmonellae in farm animals; (ii) improvements in 
slaughterhouse hygiene, (iii) prevention of cross-contamination of animal products, (iv) 
decontamination of processed foods and (v) improvements in food preparation and storage. It 
may also eventually be possible to produce vaccines for the prevention of food poisoning in 
humans. 
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In farm animals prevention depends upon: (i) sourcing feed free from salmonellae or 
decontamination of feed; (ii) reduction of contamination during rearing and transport; (iii) 
detection of carriers and infected herds/flocks; (iv) competitive-exclusion, i.e. e use of harmless 
bacteria to inhibit the growth of salmonellae in the gut of animals; (v) effective vaccination and, 
eventually (vi) the development of herds an oc s which are resistant to disease and colonisation. 
Improvements have already been made in treating animal feed to remove salmonellae and in 
preventing re-contamination of treated feed. Detection of infected her s an flocks is also possible, 
although it mainly relies on isolation of the organism. It is si not possible, however, to detect 
animals which are carriers of salmonellae in t e absence of clinical signs, which is a prerequisite 
for the elimination of infection from chronically infected herds. . 
The prevention of salmonellosis by vaccination of humans (against typhoid an paratyphoid) and 
animals has been possible for over 100 years, usually with limite success. Vaccination presents a 
number of problems, particularly since the disease may be caused by a large number of 
serotypes in both humans and animals. It ,s a necessary to produce vaccines which protect 
against disease and colonisation and the problem is made more difficult because animals are 
often infected within the first few days of life before traditional vaccines can be administered or 
induce an active immunity. This is particularly true of cattle and poultry - the possibilities for 
pigs are more optimistic. There are also problems with the use of attenuated vaccines in food -
producing animals when the vaccine may still be present when the animals are slaughtered for 
consumption. It is, however, likely that live vaccine strains will be needed to provide good 
immunity. In addition to the requirements discussed above, such vaccines sh ould: (i) be 
demonstrably avirulent in all possible host species, including immune-compromised and wild 
animals; (ii) protect against all serotypes; (iii) protect against disease and colonisation; (iv) 
have no or minimal adverse reactions - this has been a problem with killed vaccines which may 
cause hypersensitivity reactions and with some live vaccines which may retain the ability to 
produce systemic reactions and diarrhoea; (v) not revert to a virulent form and (vi) be readily 
differentiated from wild-type strains - otherwise investigations of the epidemiology of the 
disease will be compromised. 
The success of vaccination, particularly in farm animals, has been limited by a lack of 
understanding of the immune response to Salmonella infection. Although previous infection 
produces a limited protection, the mechanisms involved in domestic animals, compared to 
humans or experiment rodent models remain relatively unexplored. However, recent advances 
in our understanding of the pathogenesis of disease, colonisat ion and the development of 
protective immunity makes the development of safe, effective vaccines a possibility.  
With this improved knowledge of pathogenesis it should now be possible to design live vaccine 
strains capable of invading and inducing an effective immunity and yet lacking the genes 
responsible for the induction of enteropathogenic responses which have been a possible side 
effect of current vaccine candidates. Further knowledge of the basis of host specificity is still 
required before they can be made effective against all serotypes. 
In particular, mechanisms used by salmonellae to invade the intestinal mucosa and cause 
diarrhoea are known and the genes responsible have been described. Deletion of these genes 
from candidate live vaccine strains renders them avirulent and unable to cause diarrhoea. 
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It has long been known that some individuals in a population are more resistant to some 
infections than others and resistance to systemic salmonellosis in laboratory mice (under the 
control of the Ity or Nramp gene) was described more than 30 years ago. More recently it has 
been shown that resistance to invasive Salmonella infection in poultry is mediated by a single, 
autosomal, gene (Sall) located on chicken chromosome 5 and it has been possible 
experimentally to breed lines of resistant chickens.The Sall gene is expressed functionally in 
macrophages and is correlated with the level of oxidative burst generated as a result of 
Salmonella infection. Full identification of the gene raises the possibility of breeding commercial 
birds equally resistant, without interfering with desirable traits such as weight gain. Such breeds 
should be resistant to invasive serotypes such as S. gallinarum. They may also be resistant to 
localisation of Salmonella in the ovary, which is one of the mechanisms resulting in infection of 
eggs. Unfortunately, the same gene does not confer resistance in the alimentary tract. Further 
experiments have, however, shown that inbred lines of chickens also vary in their susceptibility 
to intestinal colonisation. Hopefully, identification of the gene(s) responsible may lead to the 
production of chickens which will not be colonised, thus reducing reliance on antibiotics for the 
control of Salmonella in commercial flocks. It is also possible that similar genes may control 
colonisation in other species, and Nrampl has been described in cattle and pigs. Families of pigs 
with different susceptibilities to experimental S. choleraesuis infection have been identified in 
research at IAH Compton. Resistance was correlated with recovery of salmonellae from the 
tissues and faeces of infected animals and resistant animals gained weight more rapidly than 
those in susceptible groups. 
In summary, recent advances in our knowledge of the pathogenesis of salmonellosis, and in 
particular mechanisms involved in colonisation and enteropathogenesis make the production of 
safe effective vaccines against systemic salmonellosis, enteritis and colonisation a possibility in 
the short term. In the longer term it should be possible to breed poultry and pigs which are 
resistant to salmonellosis and colonisation by salmonellas. 
Animal Health and Welfare ; Environmental Protection 
As already mentioned, public concern for animal welfare is increasing, leading to the 
establishment and implementation of the three Rs rule. 
The value of animal models for veterinary vaccines is not to be ignored, particularly since 
researchers have access to target animal models which are often more relevant, especially for 
challenge/protection studies. Immune protection involves complex immunological phenomena 
and processes. It is particularly true whenever cellular immunity plays a crucial role because it is 
still easier to measure antibody than cellular responses in vitro.  
Nevertheless, the trend is to replace animal models by in vitro systems whenever possible. The 
problem of the replacement of the in vivo model by the in vitro is impeded in Europe by the 
necessity to comply with Pharmacopoeia monographs where the use of laboratory and/or target 
animals is often requested. As far as the use of veterinary vaccines itself is concerned the benefit 
for animal welfare is obvious. Vaccines, unlike therapeutic treatments, are the best way of 
avoiding animal suffering since they prevent disease. Furthermore, due to the short lifetime of 
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many food-producing animals, the vaccine must only be administered once in contrast to 
treatments which generally necessitate repeated interventions. Nevertheless, there is still room 
for improvement by developing less reactogenic adjuvanted vaccines. Another area of animal 
health improvement is the use of vaccines for immunocastration of male pigs to avoid boar taint, 
instead of surgical castration. The use of vaccines in animal production systems is also often 
more environment friendly since it reduces the use of chemicals. Of special interest is the anti-
tick vaccine developed in Australia based on a cryptic intestinal antigen.  
Vaccination : an Old and outstanding Recipe to Face New 
Challenges : As a Conclusion  
VACCINATION AND VACCINES ARE FACING NEW PROBLEMS NOT YET SOLVED: 
1.adaptation to ever changing pathogens; 
2.consumer’s attitude towards vaccination;  
3.globalisation (the five Ts and transboundary diseases);  
4.harmonisation of international regulations; 
5.vaccination and disease eradication; 
6.vaccination and public health; 
7.what is the most adapted and pragmatic way to prevent or combat new and emerging 
infections in the prevailing regulatory environment while mitigating risk?  
8.what is the best attitude in the face of agro-and bio-terrorism? 
9.what is the best way to adapt tight regulations in the presence of ever evolving pathogens?  
10.what is the impact of consumers’ attitudes towards the vaccination of foodproducing animals 
as experienced during the last outbreak of foot-and-mouth disease in the European Union? 
11.how much do we need to change our attitude towards control policies, taking into 
consideration globalisation? 
12.what will be the impact of harmonisation of regulations for trade and medicinal products 
towards our attitude to vaccination? 
13.what are the diseases to be eradicated through vaccination campaigns?  
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